Inhibition of HER2 tyrosine kinase disrupts androgen-receptor functioning

被引:0
|
作者
机构
来源
Nature Clinical Practice Urology | 2005年 / 2卷 / 6期
关键词
D O I
10.1038/ncpuro0192
中图分类号
学科分类号
摘要
引用
收藏
页码:264 / 265
页数:1
相关论文
共 50 条
  • [1] Biased activation of the receptor tyrosine kinase HER2
    Claudia Catapano
    Johanna V. Rahm
    Marjan Omer
    Laura Teodori
    Jørgen Kjems
    Marina S. Dietz
    Mike Heilemann
    Cellular and Molecular Life Sciences, 2023, 80
  • [2] Biased activation of the receptor tyrosine kinase HER2
    Catapano, Claudia
    Rahm, Johanna V.
    Omer, Marjan
    Teodori, Laura
    Kjems, Jorgen
    Dietz, Marina S.
    Heilemann, Mike
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (06)
  • [3] Overexpression of the HER2/neu receptor tyrosine kinase inhibits its downregulation
    Worthylake, RA
    Wiley, HS
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1409 - 1409
  • [4] The Tyrosine Kinase Receptor HER2 (erbB-2) From Oncogenesis to Adipogenesis
    Vazquez-Martin, Alejandro
    Jose Ortega-Delgado, Francisco
    Manuel Fernandez-Real, Jose
    Menendez, Javier A.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (05) : 1147 - 1152
  • [5] HETEROGENEITY OF THE EFFECT OF COMBINED FRACTIONATED RADIOTHERAPY AND EGFR/HER2 TYROSINE KINASE INHIBITION
    Gurtner, K.
    Schuetze, C.
    Soica, F.
    Baumann, M.
    Krause, M.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S42 - S43
  • [6] Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
    Gordon, Michael A.
    D'Amato, Nicholas C.
    Gu, Haihua
    Babbs, Beatrice
    Wulfkuhle, Julia
    Petricoin, Emanuel F.
    Gallagher, Isela
    Dong, Ting
    Torkko, Kathleen
    Liu, Bolin
    Elias, Anthony
    Richer, Jennifer K.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (07) : 1389 - 1400
  • [7] Predicting response to HER2 kinase inhibition
    Settleman, Jeff
    ONCOTARGET, 2015, 6 (02) : 588 - 589
  • [8] The Role of ERBB2/HER2 Tyrosine Kinase Receptor in the Regulation of Cell Death
    A. A. Daks
    O. A. Fedorova
    O. Y. Shuvalov
    S. E. Parfenev
    N. A. Barlev
    Biochemistry (Moscow), 2020, 85 : 1277 - 1287
  • [9] The Role of ERBB2/HER2 Tyrosine Kinase Receptor in the Regulation of Cell Death
    Daks, A. A.
    Fedorova, O. A.
    Shuvalov, O. Y.
    Parfenev, S. E.
    Barlev, N. A.
    BIOCHEMISTRY-MOSCOW, 2020, 85 (10) : 1277 - 1287
  • [10] Sensitivity to the HER2 tyrosine kinase inhibitor lapatinib in breast cancer cells overexpressing truncated HER2 receptor (P95HER-2)
    Scaltriti, Maurizio
    Di Cosimo, Serena
    Ocana, Alberto
    Guzman, Marta
    Cortes, Javier
    Rojo, Federico
    Baselga, Jose
    ANNALS OF ONCOLOGY, 2006, 17 : 58 - 58